Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Erythropoietic Protoporphyria: Phase 2 Clinical Trial Results Evaluating the Safety and Effectiveness of Dersimelagon (MT-7117), an Oral MC1R Agonist
PaperCitations, authors & open-access status
Erythropoietic Protoporphyria: Phase 2 Clinical Trial Results Evaluating the Safety and Effectiveness of Dersimelagon (MT-7117), an Oral MC1R Agonist is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 12 citations, 2020 year and closed oa status.
12
Citations
2020
Year
closed
OA Status